—
C+
C+ The full Closelook — membership. Open the C+ overview

BB Biotech AG (BION.SW) — Quality & forensics

As of 2026-09-18 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.

The Closelook module scores

74 /100 composite · 7 modules · general weight set

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

4/7 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

Continue: the BION.SW chart & overview

FAQ · from the current data · as of 2026-09-18

Quick answers

What is BB Biotech AG's Closelook quality reading?

The composite reads 74/100 across 7 modules, as of 2026-09-18: valuation 81, quality 96, growth 79, balance sheet 88, cash quality 16, capital allocation 51, momentum 74. Closelook scores are research diary readings, not ratings or investment advice.

What is BB Biotech AG's Piotroski F-Score?

4 of 7, as of 2026-09-18. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

Related in the Closelook universe

then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.